Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 1, 1987
[Antitumor effects of 5'-deoxy-5-fluorouridine (5'-DFUR) against various murine tumors in combination with recombinant interferon alpha or cytostatics]
Y Ninomiya, M Miwa, H Fukuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 1, 1993
[Antitumor activity of various cytostatics in mice bearing murine advanced tumors]
K Fujimoto-Ouchi, S Tamura, K Mori, et al.
Clinical and Experimental Immunology
|
February 26, 2005
Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements
M Yamazaki, R Kitamura, S Kusano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
High susceptibility of human cancer xenografts with higher levels of cytidine deaminase to a 2'-deoxycytidine antimetabolite, 2'-deoxy-2'-methylidenecytidine
M Miwa, H Eda, M Ura, et al.
Japanese Journal of Cancer Research : Gann
|
February 1, 1990
Comparative antitumor activity and intestinal toxicity of 5'-deoxy-5-fluorouridine and its prodrug trimethoxybenzoyl-5'-deoxy-5-fluorocytidine
Y Ninomiya, M Miwa, H Eda, et al.
Cancer Research
|
April 15, 1990
Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice
Y Tanaka, H Eda, T Tanaka, et al.
Chemical & Pharmaceutical Bulletin
|
April 1, 1990
Comparative studies on the antitumor and immunosuppressive effects of the new fluorouracil derivative N4-trimethoxybenzoyl-5'-deoxy-5-fluorocytidine and its parent drug 5'-deoxy-5-fluorouridine
M Miwa, T Ishikawa, H Eda, et al.
Archives of Virology
|
January 22, 2005
A monoclonal antibody that recognizes Epstein-Barr virus nuclear antigen 2 (EBNA 2) amino acids 1-58 does not react with EBNA 2 in native form, consistent with the self-association of EBNA 2 through the amino-terminus
S Harada, M Obayashi, C Suzuki, et al.
Kanagawa Shigaku. the Journal of the Kanagawa Odontological Society
|
June 1, 1984
[A compositional study of orthodontic patients in Kanagawa Dental College (1973-1982)]
K Kuroki, H Oda, N Sagara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1995
Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft
S Tamura, K F Ouchi, K Mori, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 1, 1987
[Antitumor effects of 5'-deoxy-5-fluorouridine (5'-DFUR) against various murine tumors in combination with recombinant interferon alpha or cytostatics]
Y Ninomiya, M Miwa, H Fukuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|
December 1, 1993
[Antitumor activity of various cytostatics in mice bearing murine advanced tumors]
K Fujimoto-Ouchi, S Tamura, K Mori, et al.
Clinical and Experimental Immunology
|
February 26, 2005
Elevated immunoglobulin G antibodies to the proline-rich amino-terminal region of Epstein-Barr virus nuclear antigen-2 in sera from patients with systemic connective tissue diseases and from a subgroup of Sjögren's syndrome patients with pulmonary involvements
M Yamazaki, R Kitamura, S Kusano, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
High susceptibility of human cancer xenografts with higher levels of cytidine deaminase to a 2'-deoxycytidine antimetabolite, 2'-deoxy-2'-methylidenecytidine
M Miwa, H Eda, M Ura, et al.
Japanese Journal of Cancer Research : Gann
|
February 1, 1990
Comparative antitumor activity and intestinal toxicity of 5'-deoxy-5-fluorouridine and its prodrug trimethoxybenzoyl-5'-deoxy-5-fluorocytidine
Y Ninomiya, M Miwa, H Eda, et al.
Cancer Research
|
April 15, 1990
Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice
Y Tanaka, H Eda, T Tanaka, et al.
Chemical & Pharmaceutical Bulletin
|
April 1, 1990
Comparative studies on the antitumor and immunosuppressive effects of the new fluorouracil derivative N4-trimethoxybenzoyl-5'-deoxy-5-fluorocytidine and its parent drug 5'-deoxy-5-fluorouridine
M Miwa, T Ishikawa, H Eda, et al.
Archives of Virology
|
January 22, 2005
A monoclonal antibody that recognizes Epstein-Barr virus nuclear antigen 2 (EBNA 2) amino acids 1-58 does not react with EBNA 2 in native form, consistent with the self-association of EBNA 2 through the amino-terminus
S Harada, M Obayashi, C Suzuki, et al.
Kanagawa Shigaku. the Journal of the Kanagawa Odontological Society
|
June 1, 1984
[A compositional study of orthodontic patients in Kanagawa Dental College (1973-1982)]
K Kuroki, H Oda, N Sagara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 1, 1995
Involvement of human interleukin 6 in experimental cachexia induced by a human uterine cervical carcinoma xenograft
S Tamura, K F Ouchi, K Mori, et al.
Page
of 4